Company
The company behind FIM.
Founded in 2005, ATI develops innovative medical devices for the ophthalmological market — dramatically improving the patient's experience during diagnostic procedures while increasing clinical efficiency.
Founded in 2005, ATI develops innovative medical devices for the ophthalmological market — dramatically improving the patient's experience during diagnostic procedures while increasing clinical efficiency.
Founded in 2005 by entrepreneurs in ophthalmology and electromechanical devices.
ATI develops innovative medical devices for the ophthalmological market, which dramatically improve the patient's experience during diagnostic procedures while increasing their efficiency. ATI today employs an experienced multidisciplinary team with many groundbreaking innovations.
ATI's flagship product, FIM (Field Induced Mydriasis), is the world's first pupil dilation device. It dramatically improves the examination experience by achieving full dilation within 90–120 seconds and full recovery within minutes. FIM is a safe, non-contact and drug-free device, which has been approved by the CE.
ATI is currently developing an innovative personal ocular tonometer, called NIT, to be used by patients themselves to measure their intraocular pressure for early detection of glaucoma.
A few of the moments that got us here — the full story is on our News page.
ATI is founded by a group of seasoned entrepreneurs in ophthalmology and electromechanical devices.
FIM receives CE Marking of Conformity and the ISO 13485:2003 certificate.
Large-scale clinical research completed at Tel Aviv Sourasky Medical Center (Ichilov), Ophthalmology Department.
ATI completes design and manufacturing of the FIM Second Generation first prototype, fully in-house.
New cooperation with India's Remidio Innovative Solutions to integrate FIM into their Mobile Fundus Camera.
ATI is raising new investment to complete FIM 2nd generation and begin development of NIT. See News for details.